# Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/transarterial-chemoembolization-with-pd-l-1-inhibitors-plus-molecular-targeted/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hai‐Dong Zhu,Hai-Liang Li,Mingsheng Huang,Wei-Zhu Yang,Guowen Yin,Bin‐Yan Zhong,Junhui Sun,Zhi‐Cheng Jin,Jian-Jia Chen,Naijian Ge,Wen‐Bin Ding,Wenhui Li,Jinhua Huang,Wei Mu,Shanzhi Gu,Jiaping Li,Hui Zhao,Shu-Wei Wen,Yanming Lei,Yusheng Song,Chunwang Yuan,Weidong Wang,Ming Huang,Wei Zhao,Jianbing Wu,Song Wang,Xu Zhu,Xu Zhu,Jian-Jun Han,Wei-Xin Ren,Zaiming Lu,Wenge Xing,Yong Fan,Hai-Lan Lin,Zishu Zhang,Wenhao Hu,Qiang Tu,Qiang Tu,Hong-Ying Su,Chuan-Sheng Zheng,Yong Chen,Xuya Zhao,Qi Wang,Qi Wang,Jinwei Zhao,Jian Xu,Jian Xu,Qing-Hua Wu,Huan-Zhang Niu,Jian Wang,Feng Dai,Duiping Feng,Qing-Dong Li,Rong-Shu Shi,Jia-Rui Li,Guang Yang,Hai-Bin Shi,Jian-Song Ji,Yue Liu,Zheng Cai,Po Song Yang,Yang Zhao,Xiao-Li Zhu,Xiao-Li Zhu,Li-Gong Lu,Gao‐Jun Teng,for the CHANCE001 Investigators |
| Citations | 294 |
| DOI | 10.1038/s41392-022-01235-0 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41392-022-01235-0.pdf |
| OpenAlex ID | https://openalex.org/W4319335912 |
| PMID | 36750721 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Qi Wang](https://scholariq.org/researchers/qi-wang/)

## Paper journal

- [Signal Transduction and Targeted Therapy](https://scholariq.org/journals/signal-transduction-and-targeted-therapy/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.